Alpa Laboratories Stock Screener | Share Price & Fundamental Analysis
ALPA
Pharmaceuticals
Screen Alpa Laboratories share price with our stock screener - analyze fundamentals and track trades in your journal
Share Price NSE
₹75.89
▼
-2.47 (-3.15%)
Share Price BSE
₹76.97
▼
-1.51 (-1.92%)
Market Cap
₹162.41 Cr.
P/E Ratio (TTM)
15.00
P/B Ratio
0.89
EPS (TTM)
₹9.34
Dividend Yield
-
Debt to Equity
0.02
52W High
₹131.03
52W Low
₹75.89
Operating Margin
1.00%
Profit Margin
-4.76%
Revenue (TTM)
₹42.00
EBITDA
₹3.00
Net Income
₹-2.00
Total Assets
₹223.00
Total Equity
₹171.00
Alpa Laboratories Share Price History - Stock Screener Chart
Screen ALPA historical share price movements with interactive charts. Analyze price trends and patterns.
Alpa Laboratories Company Profile - Fundamental Screener
Screen Alpa Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for ALPA shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE385I01010
Alpa Laboratories Balance Sheet Screener - Fundamental Analysis
Fair Value AnalysisScreen ALPA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 223 | 182 | 167 | 155 | 140 | 121 | 121 | 122 | 126 | 144 |
| Current Assets | 193 | 161 | 149 | 138 | 121 | 96 | 94 | 98 | 105 | 117 |
| Fixed Assets | 21 | 12 | 7 | 9 | 7 | 6 | 8 | 10 | 15 | 15 |
| Liabilities | ||||||||||
| Total Liabilities | 223 | 182 | 167 | 155 | 140 | 121 | 121 | 122 | 126 | 144 |
| Current Liabilities | 5 | 2 | 3 | 2 | 0 | 0 | 0 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 171 | 152 | 135 | 122 | 108 | 100 | 99 | 98 | 95 | 93 |
| Share Capital | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 | 21 |
| Reserves & Surplus | 150 | 131 | 114 | 101 | 87 | 79 | 78 | 77 | 74 | 72 |
Screen ALPA income statement and profit fundamentals. Analyze revenue growth, EBITDA, net profit margins, and EPS using our fundamental screener for share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 42 | 31 | 29 | 28 | 27 | 27 | 32 | 35 | 29 | 30 | 35 | 31 | 27 | 24 | 20 |
| Expenses | 40 | 19 | 29 | 20 | 21 | 21 | 22 | 25 | 20 | 27 | 29 | 25 | 24 | 21 | 19 |
| EBITDA | 3 | 12 | 1 | 8 | 6 | 6 | 10 | 10 | 9 | 3 | 6 | 6 | 3 | 3 | 1 |
| Operating Profit % | 1.00% | 2.00% | -9.00% | 15.00% | 2.00% | 2.00% | 13.00% | 3.00% | 32.00% | -4.00% | 10.00% | 9.00% | 4.00% | 7.00% | -42.00% |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 2 | 12 | 0 | 7 | 5 | 5 | 10 | 9 | 8 | 3 | 6 | 5 | 2 | 3 | 0 |
| Tax | 4 | 0 | 0 | 3 | 0 | 0 | 2 | 0 | 3 | 0 | 0 | 1 | 6 | 0 | 0 |
| Net Profit | -2 | 12 | 0 | 4 | 5 | 5 | 8 | 9 | 5 | 3 | 6 | 5 | -4 | 3 | 0 |
| EPS | -0.95 | 5.59 | 0.05 | 1.71 | 2.42 | 2.42 | 3.66 | 4.23 | 2.12 | 1.44 | 2.75 | 2.17 | -1.70 | 1.29 | 0.10 |
Alpa Laboratories Cash Flow Screener - Liquidity Fundamentals
Screen ALPA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 18 | 4 | 9 | 10 | -2 | 18 | -1 | -13 | 17 | -22 |
| Investing Activities | -12 | -13 | 2 | -16 | 6 | -11 | -15 | -12 | -2 | -8 |
| Financing Activities | -5 | 3 | -4 | 5 | 0 | -1 | -5 | 9 | -15 | -6 |
| Net Cash Flow | 1 | -7 | 7 | 0 | 4 | 5 | -20 | -15 | 0 | -36 |
Screen ALPA shareholding pattern and ownership fundamentals. Analyze promoter holding, institutional investors, and share distribution using our screener for informed investment decisions.
| Item | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% | 57.29% |
| FII Holding | 0.35% | 0.36% | 0.40% | 0.35% | 0.74% | 0.36% | 0.50% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 37.14% | 37.28% | 37.32% | 36.80% | 36.09% | 36.65% | 36.83% | 36.84% |
| Other Holding | 5.21% | 5.06% | 4.99% | 5.55% | 5.87% | 5.70% | 5.37% | 5.86% |
| Shareholder Count | 18,542 | 18,851 | 18,872 | 19,206 | 18,885 | 18,116 | 18,690 | 18,682 |
Alpa Laboratories Dividend Screener - Share Yield Analysis
Screen ALPA dividend history and yield fundamentals. Analyze dividend payout, frequency, and returns using our stock screener for income-focused share price evaluation.
Alpa Laboratories Index Membership - Market Screener Classification
Screen ALPA by index membership and market classification. Filter stocks by major indices like NIFTY, SENSEX using our screener for systematic share price tracking.
Alpa Laboratories Market Events Screener - Corporate Actions
Screen ALPA market events and corporate actions affecting share price. Track splits, bonuses, buybacks, and major announcements using our stock screener for fundamental event analysis.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -4.36% | ||
| Annual General Meeting | NA | 10.89% | ||
| Annual General Meeting | NA | -9.25% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -5.54% |
| 2025-08-13 | 2025-08-13 | Quarterly Result Announcement | NA | -5.48% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 4.02% |
| 2025-02-13 | 2025-02-13 | Quarterly Result Announcement | NA | -12.57% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -1.67% |
Alpa Laboratories Competitors Screener - Peer Comparison
Screen ALPA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 421,299 | 40.53 | 54,729 | 9.71% | 10,980 | 46.18 |
| Divis Laboratories | 171,931 | 69.57 | 9,712 | 18.67% | 2,191 | 53.62 |
| Torrent Pharmaceuticals | 129,290 | 60.33 | 11,539 | 6.99% | 1,911 | 62.04 |
| Cipla | 121,220 | 22.48 | 28,410 | 7.12% | 5,291 | 44.91 |
| Dr Reddys Laboratories | 107,123 | 18.68 | 33,741 | 16.73% | 5,725 | 60.09 |
| Lupin | 96,535 | 22.34 | 22,910 | 13.74% | 3,306 | 60.88 |
| Zydus Life Science | 93,358 | 18.37 | 23,511 | 18.55% | 4,615 | 47.29 |
| Mankind Pharma | 92,029 | 50.91 | 12,744 | 20.90% | 2,007 | 53.62 |
| Aurobindo Pharma | 70,742 | 20.79 | 32,346 | 9.43% | 3,484 | 57.50 |
| Alkem Laboratories | 66,921 | 27.88 | 13,458 | 3.70% | 2,216 | 47.48 |
Alpa Laboratories Company Announcements - News Screener
Screen ALPA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2025-11-14 | Financial Results For The Quarter And Half Year Ended September 302025 | View |
| 2025-11-04 | Board Meeting Intimation for Board Meeting Intimation | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-29 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-27 | Closure of Trading Window | View |
| 2025-09-05 | Book Closure For The Purpose Of Annual General Meeting. | View |
| 2025-09-04 | Reg. 34 (1) Annual Report. | View |
| 2025-08-13 | Board Meeting Outcome for Alpa Laboratories Limited Has Submitted To The Exchange The Financial Results For The Period Ended Jun 30 2025. | View |
| 2025-08-01 | Board Meeting Intimation for To Consider And Approve The Financial Results For The Period Ended Jun 30 2025 And Other Business Matters. | View |
| 2025-07-05 | Disclosures under Reg. 10(7) of SEBI (SAST) Regulations 2011 | View |
| 2025-06-27 | Closure of Trading Window | View |
| 2025-06-27 | Compliances-Reg.24(A)-Annual Secretarial Compliance | View |
| 2025-06-27 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-06-27 | Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-06-27 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | View |
| 2025-06-20 | Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-06-20 | Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011 | View |
| 2025-06-20 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-06-18 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | View |
| 2025-06-18 | Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011 | View |